Clinical Trial Update: Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating regadenoson-stress MRI to identify coronary artery disease in patients with atrial fibrillation; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

Sponsor: University of Utah | Conditions: Atrial Fibrillation, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-11-07